208 related articles for article (PubMed ID: 11721319)
1. Mechanical vs intrinsic components in the improvement of brachial arterial compliance. Comparison of the effects of atenolol versus ramipril in hypertensive patients.
Armentano RL; Graf S; Ramírez AJ; Espinosa JD; Brandani L; Baglivo H; Sánchez R
Medicina (B Aires); 2001; 61(5 Pt 1):535-40. PubMed ID: 11721319
[TBL] [Abstract][Full Text] [Related]
2. Renal and cardiac effects of antihypertensive treatment with ramipril vs metoprolol in autosomal dominant polycystic kidney disease.
Zeltner R; Poliak R; Stiasny B; Schmieder RE; Schulze BD
Nephrol Dial Transplant; 2008 Feb; 23(2):573-9. PubMed ID: 17984104
[TBL] [Abstract][Full Text] [Related]
3. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
Miranda RD; Mion D; Rocha JC; Kohlmann O; Gomes MA; Saraiva JF; Amodeo C; Filho BL
Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
[TBL] [Abstract][Full Text] [Related]
4. Effect of sulfhydryl and non-sulfhydryl angiotensin-converting enzyme inhibitors on endothelial function in essential hypertensive patients.
Pasini AF; Garbin U; Nava MC; Stranieri C; Pellegrini M; Boccioletti V; Luchetta ML; Fabrizzi P; Lo Cascio V; Cominacini L
Am J Hypertens; 2007 Apr; 20(4):443-50. PubMed ID: 17386354
[TBL] [Abstract][Full Text] [Related]
5. [Renal hemodynamics and proteinuria in chronic glomerulonephritis treated with beta-receptor blockers or ace inhibitors].
Erley CM; Berger ED; Heyne N; Klass M; Krämer D; Braun N; Wolf S; Risler T
Dtsch Med Wochenschr; 1997 Aug; 122(31-32):953-8. PubMed ID: 9280714
[TBL] [Abstract][Full Text] [Related]
6. Randomized controlled trial of ACE-inhibitors and beta-blockers with and without vasodilating activity in chronic glomerulonephritis.
Erley CM; Klass M; Krämer D; Berger E; Heyne N; Braun N; Wolf S; Risler T
Int J Clin Pharmacol Ther; 1996 Nov; 34(11):504-9. PubMed ID: 8937934
[TBL] [Abstract][Full Text] [Related]
7. Effects of ACE inhibition and beta-blockade on plasminogen activator inhibitor-1 and transforming growth factor-beta1 in carotid glomus and autonomic ganglia in hypertensive rats.
Toblli JE; Grana D; Cao G; Milei J
Am J Hypertens; 2007 Mar; 20(3):326-34. PubMed ID: 17324747
[TBL] [Abstract][Full Text] [Related]
8. Large and small artery endothelial function in patients with essential hypertension--effect of ACE inhibition and beta-blockade.
Buus NH; Jørgensen CG; Mulvany MJ; Sørensen KE
Blood Press; 2007; 16(2):106-13. PubMed ID: 17612909
[TBL] [Abstract][Full Text] [Related]
9. Arterial stiffness and central hemodynamics in treated hypertensive subjects according to brachial blood pressure classification.
Safar ME; Blacher J; Protogerou A; Achimastos A
J Hypertens; 2008 Jan; 26(1):130-7. PubMed ID: 18090550
[TBL] [Abstract][Full Text] [Related]
10. Blood pressure response under chronic antihypertensive drug therapy: the role of aortic stiffness in the REASON (Preterax in Regression of Arterial Stiffness in a Controlled Double-Blind) study.
Protogerou A; Blacher J; Stergiou GS; Achimastos A; Safar ME
J Am Coll Cardiol; 2009 Feb; 53(5):445-51. PubMed ID: 19179203
[TBL] [Abstract][Full Text] [Related]
11. Differential responses of the heart and vasculature to chronic blood pressure reduction in essential hypertension.
Lafleche A; Gautier S; Topouchian J; Wilmet CS; Girerd X; Safar ME; Benetos A
Clin Pharmacol Ther; 1998 Jul; 64(1):96-105. PubMed ID: 9695724
[TBL] [Abstract][Full Text] [Related]
12. Effects of perindopril on elastic and structural properties of large arteries in essential hypertension.
Lacourcière Y; Béliveau R; Conter HS; Burgess ED; Lepage S; Pesant Y; Spence JD; Asmar R; Carrière S; Plante GE;
Can J Cardiol; 2004 Jun; 20(8):795-9. PubMed ID: 15229761
[TBL] [Abstract][Full Text] [Related]
13. Twenty-four-hour ambulatory blood pressure monitoring efficacy of perindopril/indapamide first-line combination in hypertensive patients: the REASON study.
Mallion JM; Chamontin B; Asmar R; De Leeuw PW; O'Brien E; Duprez D; O'Rourke MF; Rahn KH; Romero R; Battegay E; Hitzenberger G; Safar ME;
Am J Hypertens; 2004 Mar; 17(3):245-51. PubMed ID: 15001199
[TBL] [Abstract][Full Text] [Related]
14. Effect of losartan, compared with atenolol, on endothelial function and oxidative stress in patients with type 2 diabetes and hypertension.
Flammer AJ; Hermann F; Wiesli P; Schwegler B; Chenevard R; Hürlimann D; Sudano I; Gay S; Neidhart M; Riesen W; Ruschitzka F; Lüscher TF; Noll G; Lehmann R
J Hypertens; 2007 Apr; 25(4):785-91. PubMed ID: 17351370
[TBL] [Abstract][Full Text] [Related]
15. Impact of heart rate on central aortic pressures and hemodynamics: analysis from the CAFE (Conduit Artery Function Evaluation) study: CAFE-Heart Rate.
Williams B; Lacy PS;
J Am Coll Cardiol; 2009 Aug; 54(8):705-13. PubMed ID: 19679248
[TBL] [Abstract][Full Text] [Related]
16. Beta-blockers reduce aortic stiffness in hypertension but nebivolol, not atenolol, reduces wave reflection.
Mahmud A; Feely J
Am J Hypertens; 2008 Jun; 21(6):663-7. PubMed ID: 18437130
[TBL] [Abstract][Full Text] [Related]
17. Influence of losartan and atenolol on memory function in very elderly hypertensive patients.
Fogari R; Mugellini A; Zoppi A; Derosa G; Pasotti C; Fogari E; Preti P
J Hum Hypertens; 2003 Nov; 17(11):781-5. PubMed ID: 14578918
[TBL] [Abstract][Full Text] [Related]
18. Long-term follow-up of ACE-inhibitor versus beta-blocker treatment and their effects on blood pressure and kidney function in renal transplant recipients.
Suwelack B; Kobelt V; Erfmann M; Hausberg M; Gerhardt U; Rahn KH; Hohage H
Transpl Int; 2003 May; 16(5):313-20. PubMed ID: 12759722
[TBL] [Abstract][Full Text] [Related]
19. Different patterns of peripheral versus central blood pressure in hypertensive patients treated with β-blockers either with or without vasodilator properties or with angiotensin receptor blockers.
Polónia J; Barbosa L; Silva JA; Bertoquini S
Blood Press Monit; 2010 Oct; 15(5):235-9. PubMed ID: 20577082
[TBL] [Abstract][Full Text] [Related]
20. A 16-week, randomized, double-blind, placebo-controlled, crossover trial to quantify the combined effect of an angiotensin-converting enzyme inhibitor and a beta-blocker on blood pressure reduction.
Wald DS; Law M; Mills S; Bestwick JP; Morris JK; Wald NJ
Clin Ther; 2008 Nov; 30(11):2030-9. PubMed ID: 19108791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
